Aller au contenu principal
Accès ouvert déclaré 2025 article

Outcomes and antimicrobial usage in preterm neonates < 34 weeks gestation with culture-negative neonatal sepsis: a prospective observational study

1Citations signalées, ce qui n’est pas une note de qualité
1Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : in. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

BACKGROUND: Culture-negative sepsis (CNNS) constitutes a significant proportion of neonates admitted to the NICU. However, the outcomes and factors influencing antimicrobial therapy in this group remain understudied. METHODS: We prospectively enrolled preterm neonates (<34 weeks' gestation) with clinical features of sepsis, with or without sepsis screen positive results. Primary outcome was a composite of death, bronchopulmonary dysplasia (BPD), retinopathy of prematurity requiring treatment, Intraventricular haemorrhage ≥ 2 and periventricular leukomalacia. Details of antimicrobial therapy were also collected. RESULTS: Over an 18-month period, 172 neonates were enrolled. 104 had CNNS and 68 had culture-positive sepsis (CPNS). Primary outcome was observed in 19 (18.3%) neonates with CNNS and 25 (36.8%) with CPNS, with an adjusted odds ratio (aOR) of 0.50 (95% CI: 0.22-1.12, p = 0.095). Except for BPD, which was significantly lower in CNNS (aOR: 0.10; 95% CI: 0.02-0.52, p = 0.006), there was no statistically significant difference in other outcomes between groups. Multidrug-resistant organisms comprised 67.6% of the gram-negative bacterial isolates. Median (IQR) cumulative duration of antibiotic therapy was 5 (3-7) days in CNNS and 20.5 (15-24.3) days in CPNS. Prolonged cumulative antibiotic use was observed in 50 (48%) CNNS neonates (>5 days) and 50 (73.5%) CPNS neonates (>14 days). In CNNS group, 38 (36.5%) received second-line antibiotics, and 6 (5.7%) received third-line antibiotics. CONCLUSION: In preterm neonates, composite outcome of mortality and major morbidities did not differ significantly between those with CNNS and CPNS. However, a considerable proportion of CNNS neonates received a prolonged course of higher antibiotics. Thus, there is a need for strategies to improve clinical outcomes and strengthen adherence to antibiotic stewardship principles.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé, mais le titre doit être comparé manuellement.

Titre Crossref
Outcomes and antimicrobial usage in preterm neonates &lt; 34 weeks gestation with culture-negative neonatal sepsis: a prospective observational study
Date Crossref
06/12/2025
Éditeur
Springer Science and Business Media LLC
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Où se fait cette recherche

  • Institute of Medical Sciences and Sum Hospital pays non établi dans la notice
    Université ou école supérieure
  • IMS and SUM Hospital Department of Pediatrics pays non établi dans la notice
    Établissement de santé

Institute of Medical Sciences and Sum Hospital et Department of Pediatrics — IMS and SUM Hospital.

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Neonatal and Maternal InfectionsPreterm Birth and ChorioamnionitisInfant Nutrition and Health

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.